This is in marked contrast with observational studies [5–7] that show that severe hypoglycaemia rates remain comparable with those reported over 20 years ago [8], despite the introduction of insulin analogues, continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM). Here, INS is linked to Hypoglycemia.